SRXN1 and persistent truncus arteriosus: Moreover, compared with WT mice, AAV‐9‐Srxn1 mice exhibited dramatically ameliorated TAC‐induced cardiac dysfunction, hypertrophy, fibrosis, oxidative stress, and inflammation.